A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: Perspective of the Spanish National Health System

  1. Paz-Ares, L.
  2. Del Muro, J.G.
  3. Grande, E.
  4. Díaz, S.
Aldizkaria:
Journal of Clinical Pharmacy and Therapeutics

ISSN: 0269-4727,  1365-2710

Argitalpen urtea: 2010

Alea: 35

Zenbakia: 4

Orrialdeak: 429-438

Mota: Artikulua

DOI: 10.1111/J.1365-2710.2009.01135.X GOOGLE SCHOLAR
Datuen iturria: Scopus